Natural killer (NK) cell function in paroxysmal nocturnal hemoglobinuria: A deficiency of NK cells, but not an NK cell deficiency

Blood

Volumn 125, Issue 8, 2015, Pages 1351-1352

  El Sherbiny, Yasser M ^a,b   Doody, Gina M ^a   Kelly, Richard J ^a   Hill, Anita ^a   Hillmen, Peter ^a   Cook, Graham P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ECULIZUMAB; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL;

BONE MARROW DEPRESSION; CELLULAR IMMUNODEFICIENCY; CYTOTOXICITY; EXOCYTOSIS; GENE MUTATION; HEMATOPOIETIC STEM CELL; HEMOLYSIS; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; LARGE GRANULAR LYMPHOCYTE; LETTER; MONOCYTE; MOSAICISM; NATURAL KILLER CELL; NEUTROPHIL COUNT; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; THROMBOCYTE COUNT; VIRUS INFECTION; BLOOD; COHORT ANALYSIS; DEFICIENCY; DEGRANULATION; DISEASE PREDISPOSITION; IMMUNOLOGY; LYMPHOCYTE COUNT; PATHOLOGY; PHYSIOLOGY;

CELL DEGRANULATION; COHORT STUDIES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE SUSCEPTIBILITY; GLYCOSYLPHOSPHATIDYLINOSITOLS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; VIRUS DISEASES;

EID: 84923381058     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-07-591255     Document Type: Letter

References (10)

1. Pu JJ, Brodsky RA. Paroxysmal nocturnal hemoglobinuria from bench to bedside. Clin Transl Sci. 2011;4(3):219-224.
2. Kelly RJ, Hill A, Arnold LM, et al. Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood. 2011;117(25):6786-6792.
3. Yoda Y, Abe T, Mitamura K, et al. Deficient natural killer (NK) cell activity in paroxysmal nocturnal haemoglobinuria (PNH). Br J Haematol. 1982;52(4):559-562.
4. Yoda Y, Abe T. Deficient natural killer (NK) cells in paroxysmal nocturnal haemoglobinuria (PNH): studies of lymphoid cells fractionated by discontinuous density gradient centrifugation. Br J Haematol. 1985;60(4):669-675.
5. Orange JS. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 2002;4(15):1545-1558.
6. Orange JS. Natural killer cell deficiency. J Allergy Clin Immunol. 2013;132(3): 515-525, quiz 526.
7. Richards SJ, Norfolk DR, Swirsky DM, Hillmen P. Lymphocyte subset analysis and glycosylphosphatidylinositol phenotype in patients with paroxysmal nocturnal hemoglobinuria. Blood. 1998;92(5):1799-1806.
8. El-Sherbiny YM, Kelly RJ, Hill A, Doody GM, Hillmen P, Cook GP. Altered natural killer cell subset homeostasis and defective chemotactic responses in paroxysmal nocturnal hemoglobinuria. Blood. 2013;122(11):1887-1890.
9. Nishimura J, Kanakura Y, Ware RE, et al. Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore). 2004;83(3):193-207.
10. de Latour RP, Mary JY, Salanoubat C, et al; French Society of Hematology; French Association of Young Hematologists. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood. 2008;112(8):3099-3106.